Leading players in the Japanese contract research sector have predicted ongoing disruption to trials in the aftermath of the massive earthquake and tsunami that struck the country last week.
German machine tool maker Fette Compacting has set up a tablet compression and flowability testing centre in Goa, India.
US drug giant Pfizer may sell its generics, consumer health and Capsugel units in an effort to slim down and refocus on its core pharmaceutical business according to a number of reports.
SOCMA and the EFCG want the US FDA to make inspection of overseas API manufacturing sites mandatory, with the facilities paying for the costs themselves.
CRO and Pharma patient recruitment efforts can benefit from social networks and online patient groups, but clarification from the US FDA is still needed.
Training firm Clinical Research Site Training (CRST) has released the findings of a survey into the impact of increasingly complex clinical trials.
The Japanese drug sector seems to have survived the earthquake and tsunami that struck the country largely unscathed, with early reports suggesting that most manufacturing sites have escaped damage.
GlobalCare, the ambulatory clinical trial specialist, has announced it intends to expand its operations into Latin America.
Medtronic, the US-based medical technology firm, has officially opened its new regional headquarters building in Shanghai, China.
Wuxi PharmaTech finished the fourth quarter and the full year 2010 on a high driven by growth across all business units and the payoff from former suitor Charles River Laboratories (CRL).
Regional production hubs created by technology transfer can improve public health and drive economic development in low- to mid-income countries, says Eli Lilly
The US contract research organization (CRO) Quintiles may look at acquisitions and more ‘strategic partnerships’ after securing a $2.43bn credit facility.
US healthcare giant Johnson & Johnson (J&J) has recalled 384,000 of its insulin cartridges on concerns the products could cause serious health problems for diabetics.
Synexus is looking to expand into the US where it believes its patient recruitment model can outperform many existing trial sites.
GEA Pharma Systems, the German drug processing equipment manufacturer, has signed a representation agreement with Swedish hi-tech firm Christian Berner Tech Trade.